Complaint alleging breaches of fiduciary duties, unjust enrichment, abuse of control, and gross mismanagement in Tammy Raul, derivatively on behalf of Nominal Defendant Spectrum Pharmaceuticals Inc., described as a United Kingdom-domiciled, Ireland-based “biopharmaceutical company that develops and commercializes oncology and hematology drug products” v. Joseph W. Turgeon, Kurt A. Gustafson, Francois Lebel, William L. Ashton, Nora E. Brennan, Seth H.Z. Fischer, Juhyun Lim, Thomas J. Riga, Jeffrey Vacirca, Dolatrai M. Vyas, and Bernice R. Welles, as Defendants, and Spectrum Pharmaceuticals Inc., as Nominal Defendant, at the U. S. District Court for the District of Delaware.
43
April 28, 2022
Joseph W. Turgeon, Kurt A. Gustafson, Francois Lebel, William L. Ashton, Nora E. Brennan, Seth H.Z. Fischer, Juhyun Lim, Thomas J. Riga, Jeffrey Vacirca, Dolatrai M. Vyas, Bernice R. Welles, Spectrum Pharmaceuticals Inc.
Topics
Investment Ireland USA United KingdomKeywords
Bernice Welles Dolatrai Vyas Francois Lebel Jeffrey Vacirca Joseph Turgeon